Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Stroes

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 2, 2017
New strategies for the development of lipid-lowering therapies to reduce cardiovascular riskIan Graham, Chuck Shear, Pieter De Graeff, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and managementRobert A Hegele, Henry N Ginsberg, M John Chapman, et al.
Gut|October 26, 2021
Duodenal <i>Anaerobutyricum soehngenii</i> infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over studyAnnefleur Koopen, Julia Witjes, Koen Wortelboer, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
Journal of the American College of Cardiology|November 8, 2023
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart FailureWouter Ouwerkerk, Joao P Belo Pereira, Troy Maasland, et al.
Circulation|June 18, 2020
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 PatientsPeter Willeit, Lena Tschiderer, Elias Allara, et al.
European Heart Journal|January 13, 2025
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryAmany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 2, 2017
New strategies for the development of lipid-lowering therapies to reduce cardiovascular riskIan Graham, Chuck Shear, Pieter De Graeff, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and managementRobert A Hegele, Henry N Ginsberg, M John Chapman, et al.
Gut|October 26, 2021
Duodenal <i>Anaerobutyricum soehngenii</i> infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over studyAnnefleur Koopen, Julia Witjes, Koen Wortelboer, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
Journal of the American College of Cardiology|November 8, 2023
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart FailureWouter Ouwerkerk, Joao P Belo Pereira, Troy Maasland, et al.
Circulation|June 18, 2020
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 PatientsPeter Willeit, Lena Tschiderer, Elias Allara, et al.
European Heart Journal|January 13, 2025
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryAmany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, et al.
Pageof 5